Beam Therapeutics Inc. · NASDAQ:BEAM
Robert Nelsen reported a 5.60% stake in Beam Therapeutics Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Robert Nelsen reported a 5.60% stake in Beam Therapeutics Inc., 4,600,747 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 5.60%
- Shares
- 4,600,747
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ARCH Venture Fund IX, L.P. | 5.50% | 4,540,132 |
| ARCH Venture Fund IX Overage, L.P. | 5.50% | 4,540,132 |
| ARCH Venture Partners IX, L.P. | 5.50% | 4,540,132 |
| ARCH Venture Partners IX Overage, L.P. | 5.50% | 4,540,132 |
| ARCH Venture Partners IX, LLC | 5.50% | 4,540,132 |
| Keith Crandell | 5.50% | 4,557,862 |
| Clinton Bybee | 5.50% | 4,550,630 |
| Robert Nelsen | 5.60% | 4,600,747 |
Source
Related
- Beam Therapeutics Inc.
- Robert Nelsen
- Beam Therapeutics Inc. shareholders
- Schedule 13G/A · Robert Nelsen · May 15, 2025
- Form 4 · Evans John M. · Oct 16, 2026
- Form 4 · Cavanagh Bethany J · Oct 2, 2026
- Form 4 · Ciaramella Giuseppe · Sep 25, 2026
- Schedule 13G/A · ARK Investment Management LLC · Aug 14, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 13, 2026